文化大學機構典藏 CCUR:Item 987654321/30330
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 47126/50992 (92%)
造访人次 : 13857231      在线人数 : 214
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于CCUR ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://irlib.pccu.edu.tw/handle/987654321/30330


    题名: C型肝炎病毒蛋白酶之小分子抑製劑的電腦模擬篩選和實驗評析
    In Silico Screening and Experimental Evaluation of Small Molecule Inhibitors Against HCV NS3/4A Protease
    作者: 阮皇章
    Nguyen, Hoang-Chinh
    贡献者: 生物科技研究所
    关键词: Hepatitis C virus
    small molecule
    inhibitor
    NS3/NS4A protease
    docking
    日期: 2015-06
    上传时间: 2015-08-20 15:03:47 (UTC+8)
    摘要: Hepatitis C virus (HCV) is the major cause of chronic liver diseases, including cirrhosis, liver failure, and liver cancer with over 170 million infected people worldwide. There is not any vaccine available for HCV treatment. NS3/4A serine protease is essential for viral replication, which shows a promising drug target for developing direct-acting anti-HCV agents. In this study, 150,000 small molecule compounds were extracted from chemical library and screened against NS3/4A protease by structure-based virtual screening (PyRx sofware). Ten compounds with the highest binding affinity were selected and used to evaluate their inhibitory activity by enzyme assay. The NS3/4A protease used for inhibitory kinetic analyses was the recombinant core enzyme, NS3-GSGS-NS4A. Among 10 selected compounds, compound 1 showed the highest inhibitory activity against the NS3/4A protease with IC50 and Ki values of 2.17 μM and 0.92 μM, respectively. Compound 1 was found to be a competitive inhibitor supposed to bind directly to the protease active site. In comparison with the control, the inhibitory activity of compound 1 was two-fold higher than that of hexapeptide, DEMEEC. Our newly identified compound 1 showed a promising anti-HCV agent for further drug development. These data suggested that virtual screening by means of molecular docking may an alternative way in drug discovery and development, which could save time, reduce chemical usage and find candidates efficiently.
    显示于类别:[生物科技研究所 ] 博碩士論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML517检视/开启


    检视Licence

    在CCUR中所有的数据项都受到原著作权保护.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈